参考文献/References:
[1]殷文浩,金梦祝,戴晴.火针配合针刺治疗小腿斑块状银屑病的效果观察[J].中华全科医学,2022,20(1):117-120.[2]李妍,李明,徐薇,等.丙酸氟替卡松乳膏单独或联合卡泊三醇软膏治疗轻中度斑块状银屑病的随机自身对照研究[J].中华皮肤科杂志,2022,55(3):260-263.[3]Whitlock SM,Enos CW,Armstrong AW,et al.Management of psoriasis in patients with inflammatory bowel disease:From the Medical Board of the National Psoriasis Foundation[J].Journal of the American Academy of Dermatology,2018,78(2):383-384.[4]中华医学会皮肤性病学分会银屑病专业委员会.中国银屑病诊疗指南(2018简版)[J].中华皮肤科杂志,2019,52(4):223-230.[5]Lynch M,Malara A,Timoney I,et al.Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis(DINUP):A Randomised Controlled Clinical Trial[J].Dermatology,2021,7(5):1-8.[6]荣蓉,拱远平,时文宁.单频准分子激光联合卤米松乳膏治疗斑块型银屑病疗效及对炎性因子影响[J].中国中西医结合皮肤性病学杂志,2021,20(6):553-556.[7]王鹏,刘军麟,符磊,等.凉血消风散对寻常型银屑病血热证患者血清炎性因子及免疫功能的影响[J].中医杂志,2021,62(13):1144-1149.[8]宋颖,朱世文,王晓馨.不同剂量雷公藤多苷对寻常型银屑病样小鼠血清炎性因子的影响[J].安徽医药,2021,25(10):1934-1938.[9]Acar E,Lter N,Elbeg E.Association of leptin, resistin, and high-molecular-weight adiponectin levels with psoriasis area and severity index scores, obesity, and insulin resistance in psoriasis patients[J].Dermatologica Sinica,2019,37(1):33.[10]王玲艳,潘靖,苗钢,等.对生物制剂治疗抵抗的银屑病患者皮损部位分析[J].中华皮肤科杂志,2022,55(7):583-587.[11]胡素叶,李领娥,柴旭亚.中医外治法在治疗寻常型银屑病中的应用简述[J].中国中西医结合皮肤性病学杂志,2022,21(3):276-280.[12]张建珍,马小琴.窄谱中波紫外线联合凉血消银汤治疗银屑病的临床疗效及对血清血管内皮生长因子表达的影响[J].贵州医药,2022,46(1):80-81.[13]奚婵,熊传茜,王惠平,等.他扎罗汀和窄谱中波紫外线对银屑病基质金属蛋白酶13表达的影响[J].中华皮肤科杂志,2021,54(3):201-206.[14]张楠,田野,瞿幸.祛毒止痒汤治疗寻常型银屑病的临床价值研究[J].世界中医药,2022,17(3):404-407.[15]刘芳,李和平,窦莉莉.青黛膏联合NB-UVB对寻常型银屑病(血热证)患者的疗效研究及对IL-17和VEGF水平的影响[J].甘肃科技,2022,38(5):127-130.[16]屠远辉,吴涛,刘爱民,等.修美乐联合麻防犀角地黄汤对中重度斑块型银屑病的临床疗效及相关免疫炎症指标的影响[J].中华中医药学刊,2021,39(5):57-59.[17]高瑾,翟燕,闫梦梅.消银颗粒联合复方氟米松软膏治疗寻常型银屑病的效果研究[J].中国中西医结合皮肤性病学杂志,2021,20(5):485-486.[18]孙国强,王宏蕾,郑树茂.盐酸左西替利嗪片联合白芍总苷胶囊治疗皮炎湿疹的临床疗效[J].中华中医药学刊,2017,35(11):2915-2917.[19]宋琳毅,周乃慧,王淼淼,等.白芍总苷胶囊联合阿维A和复方氟米松治疗银屑病的临床效果[J].医学研究生学报,2017,30(8):854-857.[20]沈晓云,王倩,金建秋,等.常规治疗联合白芍总苷胶囊治疗口腔扁平苔藓的快速卫生技术评估[J].中国医院用药评价与分析,2022,22(6):735-737,743.
相似文献/References:
[1]郑文新,刘 红,汪 伟.银屑病易感基因的生物信息分析[J].医学信息,2018,31(21):1.[doi:10.3969/j.issn.1006-1959.2018.21.001]
ZHENG Wen-Xin,LIU Hong,WANG Wei.Bioinformatics Analysis of the Susceptible Genes of Psoriasis[J].Journal of Medical Information,2018,31(12):1.[doi:10.3969/j.issn.1006-1959.2018.21.001]
[2]谢 晗,曾同祥.IL-17在常见皮肤病中的作用[J].医学信息,2021,34(23):33.[doi:10.3969/j.issn.1006-1959.2021.23.009]
XIE han,ZENG Tong-xiang.Role of IL-17 in Common Skin Diseases[J].Journal of Medical Information,2021,34(12):33.[doi:10.3969/j.issn.1006-1959.2021.23.009]
[3]李小智,丁长松,黄辛迪.基于数据挖掘的中医治疗银屑病临床用药规律研究[J].医学信息,2021,34(01):4.[doi:10.3969/j.issn.1006-1959.2021.01.002]
LI Xiao-zhi,DING Chang-song,HUANG Xin-di.Research on the Law of Clinical Use of Traditional Chinese Medicine for Psoriasis Based on Data Mining[J].Journal of Medical Information,2021,34(12):4.[doi:10.3969/j.issn.1006-1959.2021.01.002]
[4]任静静,石 瑛,智艳芳,等.基于生物信息学分析筛选银屑病的关键基因[J].医学信息,2022,35(24):1.[doi:10.3969/j.issn.1006-1959.2022.24.001]
REN Jing-jing,SHI Ying,ZHI Yan-fang,et al.Screening of Key Genes in Psoriasis Based on Bioinformatics Analysis[J].Journal of Medical Information,2022,35(12):1.[doi:10.3969/j.issn.1006-1959.2022.24.001]
[5]唐 文,陈爱军.银屑病相关肾脏损害的发病机制[J].医学信息,2021,34(06):36.[doi:10.3969/j.issn.1006-1959.2021.06.010]
TANG Wen,CHEN Ai-jun.Pathogenesis of Psoriasis-related Kidney Damage[J].Journal of Medical Information,2021,34(12):36.[doi:10.3969/j.issn.1006-1959.2021.06.010]
[6]熊戌霞,蔡梦珊,吴文钦.血清鳞状细胞癌抗原在常见皮肤病中的检测价值[J].医学信息,2021,34(17):181.[doi:10.3969/j.issn.1006-1959.2021.17.050]
XIONG Xu-xia,CAI Meng-shan,WU Wen-qin.The Value of Serum Squamous Cell Carcinoma Antigen Detection in Common Skin Diseases[J].Journal of Medical Information,2021,34(12):181.[doi:10.3969/j.issn.1006-1959.2021.17.050]
[7]吴思琪,吕 健,席俊羽,等.冰黄肤乐软膏治疗银屑病的有效性和安全性的Meta分析[J].医学信息,2023,36(11):43.[doi:10.3969/j.issn.1006-1959.2023.11.008]
WU Si-qi,LYU Jian,XI Jun-yu,et al.Meta-analysis of the Efficacy and Safety of Binghuang Fule Ointment in the Treatment of Psoriasis[J].Journal of Medical Information,2023,36(12):43.[doi:10.3969/j.issn.1006-1959.2023.11.008]